Cite

HARVARD Citation

    Moserle, L. et al. (2020). Kidney cancer PDOXs reveal patient‐specific pro‐malignant effects of antiangiogenics and its molecular traits. EMBO molecular medicine. 12 (12), p. n/a. [Online]. 
  
Back to record